[1] Ng M, Fleming T, Robinson M, et al.Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic ana-lysis for the Global Burden of Disease Study 2013[J]. Lancet,2014,384(9945):766-781.
[2] Prentice AM.The emerging epidemic of obesity in deve-loping countries[J]. Int J Epidemiol,2006,35(1):93-99.
[3] 赵文华, 翟屹. 胡建平, 等. 中国超重和肥胖造成相关慢性疾病的经济负担研究[J]. 中华流行病学杂志,2006,27(7):555-559.
[4] Buchwald H, Oien DM.Metabolic/bariatric surgery worldwide 2011[J]. Obes Surg,2013,23(4):427-436.
[5] Escobar-Morreale HF, Alvarez-Blasco F, Botella-Carretero JI, et al.The striking similarities in the metabolic associations of female androgen excess and male androgen deficiency[J]. Hum Reprod,2014,29(10):2083-2091.
[6] Lim SS, Norman RJ, Davies MJ, et al.The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis[J]. Obes Rev,2013,14(2):95-109.
[7] Saboor Aftab SA, Kumar S, Barber TM.The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism[J]. Clin Endocrinol (Oxf),2013,78(3):330-337.
[8] World Health Organization Fact Sheets. Obesity and Overweight[EB/OL]. Geneva: World Health Organization,2016[2018-09-27]. http://www.who.int/gho/ncd/risk_factors/overweight_text/en/
[9] Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, et al.The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery[J]. J Clin Endocrinol Metab,2005, 90(12):6364-6369.
[10] Panidis D, Tziomalos K, Misichronis G, et al.Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study[J]. Hum Reprod,2012,27(2):541-549.
[11] Legro RS.Obesity and PCOS: implications for diagnosis and treatment[J]. Semin Reprod Med,2012,30(6):496-506.
[12] Gosman GG, King WC, Schrope B, et al.Reproductive health of women electing bariatric surgery[J]. Fertil Steril,2010,94(4):1426-1431.
[13] Catenacci VA, Hill JO, Wyatt HR.The obesity epidemic[J]. Clin Chest Med,2009,30(3):415-444.
[14] Dunaif A.Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis[J]. Endocr Rev,1997,18(6):774-800.
[15] Shah DK, Ginsburg ES.Bariatric surgery and fertility[J]. Curr Opin Obstet Gynecol,2010,22(3):248-254.
[16] Mitchell M, Armstrong DT, Robker RL, et al.Adipokines: implications for female fertility and obesity[J]. Reproduction,2005,130(5):583-597.
[17] Repaci A, Gambineri A, Pasquali R.The role of low-grade inflammation in the polycystic ovary syndrome[J]. Mol Cell Endocrinol,2011,335(1):30-41.
[18] Hofstra J, Loves S, van Wageningen B, et al. High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment[J]. Neth J Med,2008,66(3):103-109.
[19] Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study[J]. J Clin Endocrinol Metab,2010,95(4):1810-1818.
[20] Kelly DM, Jones TH.Testosterone and obesity[J]. Obes Rev,2015,16(7):581-606.
[21] Shi MD, Chao JK, Ma MC, et al.Factors associated with sex hormones and erectile dysfunction in male Taiwanese participants with obesity[J]. J Sex Med,2014,11(1):230-239.
[22] Corona G, Vignozzi L, Sforza A, et al.Obesity and late-onset hypogonadism[J]. Mol Cell Endocrinol,2015,418Pt2:120-133.
[23] Wu FC, Tajar A, Pye SR, et al.Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study[J]. J Clin Endocrinol Metab,2008,93(7):2737-2745.
[24] Caprio M, Fabbrini E, Isidori AM, et al.Leptin in reproduction[J]. Trends Endocrinol Metab,2001,12(2):65-72.
[25] Kalyani RR, Dobs AS.Androgen deficiency, diabetes, and the metabolic syndrome in men[J]. Curr Opin Endocrinol Diabetes Obes,2007,14(3):226-234.
[26] Morelli A, Sarchielli E, Comeglio P, et al.Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits[J]. Mol Cell Endocrinol,2014,382(1):107-119.
[27] Loves S, Ruinemans-Koerts J, de Boer H. Letrozole once a week normalizes serum testosterone in obesity-related male hypogonadism[J]. Eur J Endocrinol,2008,158(5):741-747.
[28] Corona G, Rastrelli G, Monami M, et al.Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis[J]. Eur J Endocrinol,2013,168(6):829-843.
[29] Kiddy DS, Hamilton-Fairley D, Bush A, et al.Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome[J]. Clin Endocrinol (Oxf),1992,36(1):105-111.
[30] Domecq JP, Prutsky G, Mullan RJ, et al.Lifestyle modification programs in polycystic ovary syndrome: systema-tic review and meta-analysis[J]. J Clin Endocrinol Metab,2013,98(12):4655-4663.
[31] Crosignani PG, Colombo M, Vegetti W, et al.Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet[J]. Hum Reprod,2003,18(9):1928-1932.
[32] Eid GM, McCloskey C, Titchner R, et al. Changes in hormones and biomarkers in polycystic ovarian syndrome treated with gastric bypass[J]. Surg Obes Relat Dis,2014, 10(5):787-791.
[33] Balen AH, Morley LC, Misso M, et al.The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance[J]. Hum Reprod Update,2016,22(6):687-708.
[34] Skubleny D, Switzer NJ, Gill RS, et al.The impact of bariatric surgery on polycystic ovary syndrome: a syste-matic review and meta-analysis[J]. Obes Surg,2016,26(1):169-176.
[35] Escobar-Morreale HF, Santacruz E, Luque-Ramirez M, et al.Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis[J]. Hum Reprod Update,2017,23(4):390-408.
[36] Xydakis AM, Case CC, Jones PH, et al.Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction[J]. J Clin Endocrinol Metab,2004,89(6):2697-2703.
[37] Faraj M, Havel PJ, Phélis S, et al.Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects[J]. J Clin Endocrinol Metab,2003,88(4):1594-1602.
[38] Uzun H, Zengin K, Taskin M, et al.Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding[J]. Obes Surg,2004, 14(5):659-665.
[39] Vendrell J, Broch M, Vilarrasa N, et al.Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity[J]. Obes Res,2004,12(6):962-971.
[40] Turkmen S, Andreen L, Cengiz Y.Effects of Roux-en-Y gastric bypass surgery on eating behaviour and allopregnanolone levels in obese women with polycystic ovary syndrome[J]. Gynecol Endocrinol,2015,31(4):301-305.
[41] Hendriks ML, Ket JC, Hompes PG, et al.Why does ova-rian surgery in PCOS help? Insight into the endocrine implications of ovarian surgery for ovulation induction in polycystic ovary syndrome[J]. Hum Reprod Update,2007, 13(3):249-264.
[42] Luconi M, Samavat J, Seghieri G, et al.Determinants of testosterone recovery after bariatric surgery: is it only a matter of reduction of body mass index?[J]. Fertil Steril,2013,99(7):1872-1879.
[43] Botella-Carretero JI, Balsa JA, Gomez-Martin JM, et al.Circulating free testosterone in obese men after bariatric surgery increases in parallel with insulin sensitivity[J]. J Endocrinol Invest,2013,36(4):227-232.
[44] Calderón B1, Galdón A, Calañas A, et al. Effects of bariatric surgery on male obesity-associated secondary hypogonadism: comparison of laparoscopic gastric bypass with restrictive procedures[J]. Obes Surg,2014,24(10):1686-1692.
[45] Aarts E, van Wageningen B, Loves S, et al. Gonadal status and outcome of bariatric surgery in obese men[J]. Clin Endocrinol(Oxf),2014,81(3):378-386.
[46] 朱翠玲, 张怡, 王兴纯, 等. 腹腔镜袖状胃切除术对男性重度肥胖患者性激素水平的影响及机制探讨[J]. 中华胃肠外科杂志,2017,20(4):405-410.
[47] Gao J, Zhang M, Zhu C, et al.The change in the percent of android and gynoid fat mass correlated with increased testosterone after laparoscopic sleeve gastrectomy in Chinese obese men: a 6-month follow-up[J]. Obes Surg,2018, 28(7):1960-1965.
[48] Samavat J, Facchiano E, Lucchese M, et al.Hypogonadism as an additional indication for bariatric surgery in male morbid obesity?[J]. Eur J Endocrinol,2014,171(5):555-560.
[49] di Frega AS, Dale B, Di Matteo L, et al. Secondary male factor infertility after Roux-en-Y gastric bypass for morbid obesity: case report[J]. Hum Reprod,2005,20(4):997-998.
[50] Lazaros L, Hatzi E, Markoula S, et al.Dramatic reduction in sperm parameters following bariatric surgery: report of two cases[J]. Andrologia,2012,44(6):428-432.
[51] Legro RS, Kunselman AR, Meadows JW, et al.Time-related increase in urinary testosterone levels and stable semen analysis parameters after bariatric surgery in men[J]. Reprod Biomed Online,2015,30(2):150-156.
[52] Reis LO, Zani EL, Saad RD, et al.Bariatric surgery does not interfere with sperm quality--a preliminary long-term study[J]. Reprod Sci,2012,19(10):1057-1062.
[53] El Bardisi H, Majzoub A, Arafa M, et al.Effect of bariatric surgery on semen parameters and sex hormone concentrations: a prospective study[J]. Reprod Biomed Online,2016,33(5):606-611.
[54] Pham NH, Bena J, Bhatt DL, et al.Increased free testosterone levels in men with uncontrolled type 2 diabetes five years after randomization to bariatric surgery[J]. Obes Surg,2018,28(1):277-280.
